Zurich, Switzerland

David Hurwitz

This inventor holds 1 USPTO granted patent. Top assignee: Paul Scherrer Institut. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Hurwitz. Retrieved from https://idiyas.com/inventor/david-hurwitz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: David Hurwitz: Innovator in Protein Modification

Introduction

David Hurwitz is a prominent inventor based in Zurich, Switzerland. He has made significant contributions to the field of protein modification, particularly through his innovative patent that focuses on site-specific conjugation techniques. His work is essential for advancing therapeutic applications in biotechnology.

Latest Patents

David Hurwitz holds a patent titled "Site-specific conjugation to antibody lysine residues with solid-phase immobilized microbial transglutaminase MTG and MTG in solution." This patent describes a powerful and versatile strategy for the controlled modification of proteins under physiological conditions. The method utilizes solid-phase microbead-immobilization to efficiently attach various functional molecules to proteins of therapeutic relevance, including scFV, Fab-fragment, and antibodies. The immobilized MTG enzyme demonstrates enhanced selectivity towards specific residues, ensuring effective conjugation even in the presence of multiple reactive sites.

Career Highlights

David Hurwitz is affiliated with the Paul Scherrer Institut, where he continues to push the boundaries of protein engineering. His research has led to the generation of dual site-specifically conjugated IgG1 antibodies, showcasing his expertise in the field. The ability to site-specifically conjugate glutamine and lysine residues of IgG1 antibodies is a notable achievement that highlights his innovative approach to protein modification.

Collaborations

David has collaborated with esteemed colleagues such as Philipp Rene Spycher and Martin Behe. These partnerships have further enriched his research and contributed to the advancement of protein modification techniques.

Conclusion

David Hurwitz is a key figure in the field of protein modification, with a focus on site-specific conjugation methods that hold great promise for therapeutic applications. His innovative work continues to influence the biotechnology landscape, paving the way for future advancements in protein engineering.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…